Actinidia chinensis Planch. root extract attenuates hypoxia-induced hepatic stellate cell activation and epithelial–mesenchymal transition in hepatocellular carcinoma by inhibiting inflammatory cytokine secretion

Abstract

IntroductionHepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Several studies have demonstrated the potency of Chinese herbs in protecting the liver from inflammation, hypoxia, fibrosis, and cancer. The roots of Actinidia chinensis Planch. exhibit strong anti-tumour effects; however, their mechanisms of action in HCC are not clearly understood. MethodsTo investigate the molecular mechanisms underlying the anti-cancer effect of A chinensis Planch. root extract (acRoot) in HCC and hepatic stellate cells (HSCs). The HSC line LX2 and HCC cell line MHCC97H were cultured under oxygen-rich or oxygen-deprived conditions and then exposed to various acRoot concentrations for different periods. Subsequently, cell viability, cytotoxicity, and enzyme-linked immunosorbent assays and western blotting were conducted to assess the effects of acRoot treatment. ResultsacRoot decreased the number of viable LX2 and MHCC97H cells in a concentration- and time-dependent manner. Under hypoxic and/or co-culture conditions, pro-inflammatory cytokine expression was up-regulated in both cell lines; however, the expression levels were significantly decreased following treatment with acRoot. Additionally, acRoot inhibited hypoxia-induced activation of LX2 cells and inflammation and epithelial–mesenchymal transition (EMT) in MHCC97H cells. Moreover, acRoot inhibited cross-talk between LX2 and MHCC97H cells, further inhibiting cellular activation, inflammation, and EMT. ConclusionThese results show the therapeutic potential of acRoot as an anti-cancer, anti-inflammatory, and anti-fibrotic agent, shedding new light on the medicinal properties of Chinese herbs.